We’re proud to unveil our fourth annual results report, showcasing three years of real-world outcomes and further establishing Calibrate’s position as the only obesity management company delivering longitudinal data of this magnitude. Our annual report highlights NEW data on: -A longitudinal three-year dataset from a real-world cohort -Maintaining weight loss after stopping GLP-1 medication -Proven health improvements through lifestyle changes alone -Sustainable outcomes for those with disrupted medication access -Continuation of habits learned through Calibrate even after the program ends The 2025 Results Report solidifies Calibrate’s position as the only company offering three years of real-world data that combines GLP-1 medications with intensive lifestyle intervention. We’re proud to set a new standard for sustainable weight management and to redefine what’s possible in obesity care. Learn more about our new 2025 Results Report: https://lnkd.in/eBA3MqDQ #2025ResultsReport #RealOutcomes #WeightManagement
Calibrate’s Post
More Relevant Posts
-
Today, we’re excited to share Calibrate’s 2025 Results Report, marking our fourth year of delivering real-world data that’s redefining the future of obesity care. At Calibrate, we know that achieving sustainable results goes beyond quick fixes or GLP medications alone. This year’s report showcases our commitment to delivering measurable, long-term impact, supported by the most robust data in the industry. Combining GLP-1 medications with intensive lifestyle intervention and support isn’t just innovative, it’s essential for achieving lasting outcomes. As the only company providing this level of longitudinal data, Calibrate is leading the way in transforming obesity care. We’re not just delivering results for our members; we’re advancing real-world evidence to move the entire field forward. This is how we’re changing the way the world treats weight.
We’re proud to unveil our fourth annual results report, showcasing three years of real-world outcomes and further establishing Calibrate’s position as the only obesity management company delivering longitudinal data of this magnitude. Our annual report highlights NEW data on: -A longitudinal three-year dataset from a real-world cohort -Maintaining weight loss after stopping GLP-1 medication -Proven health improvements through lifestyle changes alone -Sustainable outcomes for those with disrupted medication access -Continuation of habits learned through Calibrate even after the program ends The 2025 Results Report solidifies Calibrate’s position as the only company offering three years of real-world data that combines GLP-1 medications with intensive lifestyle intervention. We’re proud to set a new standard for sustainable weight management and to redefine what’s possible in obesity care. Check out the comments below for a link to our latest results! #2025ResultsReport #RealOutcomes #WeightManagement
To view or add a comment, sign in
-
The 2025 Results Report is here, and it’s more than just data—it’s proof of the real, lasting impact we’re making on people’s health and lives. Sustained weight loss, improved metabolic health, and remarkable outcomes—this is the power of the Metabolic Reset. As a marketer, I couldn’t be more excited to promote these results with integrity. It’s a reminder that behind every number is a person whose health journey we’ve transformed! 💡 If you’re curious about how Calibrate can drive better health outcomes for your organization or want to explore opportunities to collaborate, let’s connect. Together, we can change the way the world treats weight.
We’re proud to unveil our fourth annual results report, showcasing three years of real-world outcomes and further establishing Calibrate’s position as the only obesity management company delivering longitudinal data of this magnitude. Our annual report highlights NEW data on: -A longitudinal three-year dataset from a real-world cohort -Maintaining weight loss after stopping GLP-1 medication -Proven health improvements through lifestyle changes alone -Sustainable outcomes for those with disrupted medication access -Continuation of habits learned through Calibrate even after the program ends The 2025 Results Report solidifies Calibrate’s position as the only company offering three years of real-world data that combines GLP-1 medications with intensive lifestyle intervention. We’re proud to set a new standard for sustainable weight management and to redefine what’s possible in obesity care. Check out the comments below for a link to our latest results! #2025ResultsReport #RealOutcomes #WeightManagement
To view or add a comment, sign in
-
We’re proud to unveil our fourth annual results report, showcasing three years of real-world outcomes and further establishing Calibrate’s position as the only obesity management company delivering longitudinal data of this magnitude. Our annual report highlights NEW data on: -A longitudinal three-year dataset from a real-world cohort -Maintaining weight loss after stopping GLP-1 medication -Proven health improvements through lifestyle changes alone -Sustainable outcomes for those with disrupted medication access -Continuation of habits learned through Calibrate even after the program ends The 2025 Results Report solidifies Calibrate’s position as the only company offering three years of real-world data that combines GLP-1 medications with intensive lifestyle intervention. We’re proud to set a new standard for sustainable weight management and to redefine what’s possible in obesity care. Check out the comments below for a link to our latest results! #2025ResultsReport #RealOutcomes #WeightManagement
To view or add a comment, sign in
-
OUTSTANDING results from the recently released three year study! It's no secret obesity is one of the major drivers in increasing overall healthcare costs. 42% of the U.S. population is currently obese. Is your organization looking for a proven, long-term solutions to provide a resource for obesity, nutrition, coaching, and the ever-increasing GLP-1 demand? Let's discuss how Calibrate can help!
We’re proud to unveil our fourth annual results report, showcasing three years of real-world outcomes and further establishing Calibrate’s position as the only obesity management company delivering longitudinal data of this magnitude. Our annual report highlights NEW data on: -A longitudinal three-year dataset from a real-world cohort -Maintaining weight loss after stopping GLP-1 medication -Proven health improvements through lifestyle changes alone -Sustainable outcomes for those with disrupted medication access -Continuation of habits learned through Calibrate even after the program ends The 2025 Results Report solidifies Calibrate’s position as the only company offering three years of real-world data that combines GLP-1 medications with intensive lifestyle intervention. We’re proud to set a new standard for sustainable weight management and to redefine what’s possible in obesity care. Check out the comments below for a link to our latest results! #2025ResultsReport #RealOutcomes #WeightManagement
To view or add a comment, sign in
-
To order Breezing products or to obtain more information, contact us at info@breezing.co www.breezing.com 480-629-5360 Current Obesity Management Problems - Metabolic Adaptation and Inflexibility. Breezing has helped improve weight management since 2011 worldwide! Key to sustain the lost weight is to maintain healthy lifestyles. Clinical studies indicate Breezing improves 70% more for patient adherence to healthier lifestyles and helps prevent weight regain.
To view or add a comment, sign in
-
-
Study reveals promising early outcomes of NHS Digital Weight Management Programme Obesity is a pressing global health challenge, linked to various chronic diseases such as type 2 diabetes, cardiovascular issues, and certain cancers. In response to this growing concern, the NHS launched the Digital Weight Management Programme in April 2021, marking a significant step towards addressing obesity at a national level. The NHS Digital Weight Management Programme stands out as the first nationally available service of its kind, offering digital interventions to help adults manage their weight effectively. Unlike traditional face-to-face interventions, this program is delivered digitally, allowing for scalability and accessibility across different levels of intensity. A recent study, co-authored by Dr. Priyantha Jayawardane and Neil Davies from the NHS Midlands and Lancashire’s Digital Innovation Unit, marks the first comprehensive evaluation of this pioneering program. Published in the Obesity: A Research Journal by The Obesity Society, the study provides valuable insights into the early outcomes of referrals to the NHS Digital Weight Management Programme. You can read more about the study here: https://lnkd.in/dFDEum8C #NHS #WeightManagement #Obesity #HealthcareInnovation #DigitalHealth #PublicHealth #HealthyLiving #Research #HealthTech
To view or add a comment, sign in
-
-
Join us for an interprofessional webinar to explore how the care team can work together to help patients and clients win the fight against obesity. Discuss how the new world of pharmacological interventions should not – and does not – edge out the importance of living a healthy lifestyle: tinyurl.com/mr4xt2sa
To view or add a comment, sign in
-
-
Join us for an interprofessional webinar to explore how the care team can work together to help patients and clients win the fight against obesity. Discuss how the new world of pharmacological interventions should not – and does not – edge out the importance of living a healthy lifestyle: tinyurl.com/mr4xt2sa
To view or add a comment, sign in
-
-
Join us for an interprofessional webinar to explore how the care team can work together to help patients and clients win the fight against obesity. Discuss how the new world of pharmacological interventions should not – and does not – edge out the importance of living a healthy lifestyle: tinyurl.com/mr4xt2sa
To view or add a comment, sign in
-
-
Join our Obesity & Weight Management Training to learn essential skills in obesity pathophysiology, lifestyle interventions, treatment options, and hands-on injectable training. Let’s make a difference together in weight management! 💊 Book today to secure your spot at our discounted rate! Click the link to join! https://lnkd.in/eUVZwjQJ #PharmacistTraining #WeightManagement #ObesityCare #PatientSupport #AlliedHealthTraining Obesity Matters
To view or add a comment, sign in
-
Learn more about Calibrate's new 2025 Results Report: https://lnkd.in/edm7UsZp